Enter your contact details & our Business Development
expert will circle back to address your request!
Published on 10/26/2021| Code: CMM460001| Category: Food & Beverages| Total Pages: 204
Global Xanthohumol Market: Description
Xanthohumol is a flavonoid cancer prevention agent atom extricated from the female blossoms of the bounces plant. It has chemo-preventive and antineoplastic properties. It is utilized in the anticipation of different degenerative sicknesses like malignant growth and cardiovascular infections.
Xanthohumol offers a few medical advantages. For example, it controls fat digestion and capacity.
It additionally regulates fatty oil and cholesterol levels as well as keeps up with glucose and insulin levels in the human body.
Xanthohumol is multiple times more grounded than resveratrol, a cancer prevention agent tracked down normally in red wine.
It additionally safeguards against free revolutionaries contrasted with cancer prevention agents present in green tea and red wine.
Global Xanthohumol Market: Overview
The global xantoumol market was worth USD 208.88 million in 2020 and is anticipated to accumulate a valuation of USD 344.81 by 2030, amplifying at a CAGR of 5.14% over the forecast period of 2022-2030.
Xanthohumol meaningfully affects more than 60 sorts of malignant growth happening in people.
These incorporate leukaemia, cellular breakdown in the lungs, colon disease, bosom malignant growth, and prostate malignant growth.
Xanthohumol forestalls the action of cyclooxygenase and lipoxygenase; and takes out infected microorganisms, infections, and organisms.
It additionally decreases skin inflammation.
Xanthohumol is found in cocktails like brew and has a place with a class of mixtures that upholds the degree of harshness and kind of bounces
Key Trends of the Global Xanthohumol Market:
A rise in Cancer patients drives the market growth
As indicated by the World Health Organization (WHO), malignant growth is the subsequent driving reason for death from one side of the planet to the other, with around 9.6 million passings in 2018.
Low and working class pay nations represented practically 70% of these passings. Tobacco causes 22% of malignant growth passings.
A rise in patients in the upcoming year will thrive the market growth
Liquor utilization, high weight file, low foods grown from the ground admission, and absence of actual work are the essential elements for around 33% of disease passings.
Hepatitis, human papilloma infection (HPV), and other disease-causing contaminations are established in around 25% of malignant growth passings in centre pay nations.
Expansion in disease cases in low and centre pay nations is expected to drive the interest in xanthohumol during the anticipating time frame.
Xanthohumol in jumps is accepted to have hostile to restenotic impacts.
It can assist with loosening up veins and further developing blood flow. Xanthohumol additionally helps lower the risk of cardiovascular infections. This is one of the critical drivers of the xanthohumol market.
Segmental Analysis of Global Xanthohumol Market:
Based on Purity
Based on End-User
Based on Region
NORTH AMERICA
Canada
US
EUROPE
UK
Germany
France
Italy
Spain
Russia
CIS
ASIA-PACIFIC
China
Japan
India
ASEAN
LATIN AMERICA
Mexico
Brazil
Competitive Landscape:
Scope of the report:
Base Year- 2020
Historical Year- 2018-2021
Forecast Year- 2022-2030
CAGR- 5.14%
USD Value in 2020- USD 208.88 million
USD Value in 2030- USD 344.81 million
Segments Covered- Region, End-user and Purity
1 Global Xanthohumol Market Introduction and Market Overview
1.1 Objectives of the Study
1.2 Market Scope & Market Segmentation
1.2.1 Purity of Global Xanthohumol Market
1.2.2 Application of Global Xanthohumol Market
1.2.3 Region of Global Xanthohumol Market
1.3 Overview/Snapshot of Global Xanthohumol Market
2 Market Dynamics
2.1 Drivers
2.2 Restraints
2.3 Opportunities
2.4. Pricing Analysis
3 Industry Analysis
3.1 Assessment of the Overall Impact of COVID-19 on the Industry
3.2 Porter’s Analysis
3.3 Supply Chain Analysis
3.4 PEST Analysis
4. Global Xanthohumol Market: Forecast By Purity Estimates & Trend Analysis
4.1. Global Xanthohumol Market, by Purity 2016 to 2028 (By Value)
4.2. Global Xanthohumol Market, by Purity 2016 to 2028 (By Volume)
98%-99%
Below 98%
Above 99%
5. Global Xanthohumol Market: Forecast By Application Estimates & Trend Analysis
5.1. Global Xanthohumol Market, By Application 2016 to 2028 (By Value)
5.2. Global Xanthohumol Market, By Application 2016 to 2028 (By Volume)
Pharmaceuticals
Food & Beverages
Cosmetics
5.3. Europe Xanthohumol Market, by Country 2016 to 2028 (By Value)
5.4. Europe Xanthohumol Market, by Country 2016 to 2028 (By Volume)
5.2.1. Europe Xanthohumol Market, by Purity 2016 to 2028 (By Value)
5.2.2. Europe Xanthohumol Market, by Purity 2016 to 2028 (By Volume)
5.2.3. Europe Xanthohumol Market, by Application 2016 to 2028 (By Value)
5.2.4. Europe Xanthohumol Market, by Application 2016 to 2028 (By Volume)
5.5. Asia Pacific Xanthohumol Market, by Country 2016 to 2028 (By Value)
5.6. Asia Pacific Xanthohumol Market, by Country 2016 to 2028 (By Volume)
5.6.1. Asia Pacific Xanthohumol Market, by Purity 2016 to 2028 (By Value)
5.6.2. Asia Pacific Xanthohumol Market, by Purity 2016 to 2028 (By Volume)
5.6.3. Asia Pacific Xanthohumol Market, by Application 2016 to 2028 (By Value)
5.6.4. Asia Pacific Xanthohumol Market, by Application 2016 to 2028 (By Volume)
5.7. South America Xanthohumol Market, by Country 2016 to 2028 (By Value)
5.8. South America Xanthohumol Market, by Country 2016 to 2028 (By Volume)
5.8.1. South America Xanthohumol Market, by Purity 2016 to 2028 (By Value)
5.8.2. South America Xanthohumol Market, by Purity 2016 to 2028 (By Volume)
5.8.3. South America Xanthohumol Market, by Application 2016 to 2028 (By Value)
5.8.4. South America Xanthohumol Market, by Application 2016 to 2028 (By Volume)
5.9. Middle East & Africa Xanthohumol Market, by Country 2016 to 2028 (By Value)
5.10. Middle East & AfricaXanthohumol Market, by Country 2016 to 2028 (By Volume)
5.10.1. Middle East & Africa Xanthohumol Market, by Purity 2016 to 2028 (By Value)
5.10.2. Middle East & Africa Xanthohumol Market, by Purity 2016 to 2028 (By Volume)
5.10.3. Middle East & Africa Xanthohumol Market, by Application 2016 to 2028 (By Value)
5.10.4. Middle East & Africa Xanthohumol Market, by Application 2016 to 2028 (By Volume)
6. Competitive Index
6.1. Competitive Landscape
6. Global Xanthohumol Market: Forecast By Region Estimates & Trend Analysis
6.1. North America Xanthohumol Market, by Country 2016 to 2028 (By Value)
6.2. North America Xanthohumol Market, by Country 2016 to 2028 (By Volume)
6.2.1. North America Xanthohumol Market, by Purity 2016 to 2028 (By Value)
6.2.2. North America Xanthohumol Market, by Purity 2016 to 2028 (By Volume)
6.2.3. North America Xanthohumol Market, by Application 2016 to 2028 (By Value)
6.2.4. North America Xanthohumol Market, by Application 2016 to 2028 (By Volume)
7. Company Profile
7.1 BetaTec Hop Products
7.1.1 Company Overview
7.1.2 Business Overview
7.1.3 Financial Information
7.1.4 Recent Developments
7.2 AQUANOVA AG
7.2.1 Company Overview
7.2.2 Business Overview
7.2.3 Financial Information
7.2.4 Recent Developments
7.3 BioVision, Inc.
7.3.1 Company Overview
7.3.2 Business Overview
7.3.3 Financial Information
7.3.4 Recent Developments
7.4 AXEN BIO GROUP
7.4.1 Company Overview
7.4.2 Business Overview
7.4.3 Financial Information
7.4.4 Recent Developments
7.5 Santa Cruz Biotechnology Inc.
7.5.1 Company Overview
7.5.2 Business Overview
7.5.3 Financial Information
7.5.4 Recent Developments
7.6 BioCrick BioTech
7.6.1 Company Overview
7.6.2 Business Overview
7.6.3 Financial Information
7.6.4 Recent Developments
7.7 Merck KGaA
7.7.1 Company Overview
7.7.2 Business Overview
7.7.3 Financial Information
7.7.4 Recent Developments
7.8 TCI
7.8.1 Company Overview
7.8.2 Business Overview
7.8.3 Financial Information
7.8.4 Recent Developments
7.9 AdooQ BioScience
7.9.1 Company Overview
7.9.2 Business Overview
7.9.3 Financial Information
7.9.4 Recent Developments
7.10 XANTO Sp. z o.o.
7.10.1 Company Overview
7.10.2 Business Overview
7.10.3 Financial Information
7.10.4 Recent Developments
8. Research Methodology
Please fill form below:
USA: +1(929)-450-2887
USA: +1(650)-666-4592
99 WALL STREET #2124 NEW YORK, NY 10005